2-(8-fluoroquinoxalin-2-yl)-5-[3-[5-(8-fluoroquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;methane;2-(8-methylquinoxalin-2-yl)-5-[3-[5-(8-methylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,7-naphthyridin-2-yl)-5-[3-[5-(1,7-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,8-naphthyridin-2-yl)-5-[3-[5-(1,8-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(6-phenylpyrimidin-4-yl)-5-[3-[5-(6-phenylpyrimidin-4-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(7-phenylquinoxalin-2-yl)-5-[3-[5-(7-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(8-phenylquinoxalin-2-yl)-5-[3-[5-(8-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-pyrimidin-2-yl-5-[3-(5-pyrimidin-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-1,3,4-oxadiazole;2-[8-(trifluoromethyl)quinoxalin-2-yl]-5-[3-[5-[8-(trifluoromethyl)quinoxalin-2-yl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole

C265H170F8N72O18 — CID 161363274

IUPAC2-(8-fluoroquinoxalin-2-yl)-5-[3-[5-(8-fluoroquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;methane;2-(8-methylquinoxalin-2-yl)-5-[3-[5-(8-methylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,7-naphthyridin-2-yl)-5-[3-[5-(1,7-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,8-naphthyridin-2-yl)-5-[3-[5-(1,8-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(6-phenylpyrimidin-4-yl)-5-[3-[5-(6-phenylpyrimidin-4-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(7-phenylquinoxalin-2-yl)-5-[3-[5-(7-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(8-phenylquinoxalin-2-yl)-5-[3-[5-(8-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-pyrimidin-2-yl-5-[3-(5-pyrimidin-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-1,3,4-oxadiazole;2-[8-(trifluoromethyl)quinoxalin-2-yl]-5-[3-[5-[8-(trifluoromethyl)quinoxalin-2-yl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole
SMILESC.C.C.C.C.C.C.Cc1cccc2ncc(-c3nnc(-c4cccc(-c5nnc(-c6cnc7cccc(C)c7n6)o5)c4)o3)nc12.FC(F)(F)c1cccc2ncc(-c3nnc(-c4cccc(-c5nnc(-c6cnc7cccc(C(F)(F)F)c7n6)o5)c4)o3)nc12.Fc1cccc2ncc(-c3nnc(-c4cccc(-c5nnc(-c6cnc7cccc(F)c7n6)o5)c4)o3)nc12.c1cc(-c2nnc(-c3ccc4cccnc4n3)o2)cc(-c2nnc(-c3ccc4cccnc4n3)o2)c1.c1cc(-c2nnc(-c3ccc4ccncc4n3)o2)cc(-c2nnc(-c3ccc4ccncc4n3)o2)c1.c1ccc(-c2cc(-c3nnc(-c4cccc(-c5nnc(-c6cc(-c7ccccc7)ncn6)o5)c4)o3)ncn2)cc1.c1ccc(-c2ccc3ncc(-c4nnc(-c5cccc(-c6nnc(-c7cnc8ccc(-c9ccccc9)cc8n7)o6)c5)o4)nc3c2)cc1.c1ccc(-c2cccc3ncc(-c4nnc(-c5cccc(-c6nnc(-c7cnc8cccc(-c9ccccc9)c8n7)o6)c5)o4)nc23)cc1.c1cnc(-c2nnc(-c3cccc(-c4nnc(-c5ncccn5)o4)c3)o2)nc1
InChIInChI=1S/2C38H22N8O2.C30H18N8O2.C28H12F6N8O2.C28H18N8O2.C26H12F2N8O2.2C26H14N8O2.C18H10N8O2.7CH4/c1-3-10-23(11-4-1)27-16-8-18-29-33(27)41-31(21-39-29)37-45-43-35(47-37)25-14-7-15-26(20-25)36-44-46-38(48-36)32-22-40-30-19-9-17-28(34(30)42-32)24-12-5-2-6-13-24;1-3-8-23(9-4-1)25-14-16-29-31(19-25)41-33(21-39-29)37-45-43-35(47-37)27-12-7-13-28(18-27)36-44-46-38(48-36)34-22-40-30-17-15-26(20-32(30)42-34)24-10-5-2-6-11-24;1-3-8-19(9-4-1)23-15-25(33-17-31-23)29-37-35-27(39-29)21-12-7-13-22(14-21)28-36-38-30(40-28)26-16-24(32-18-34-26)20-10-5-2-6-11-20;29-27(30,31)15-6-2-8-17-21(15)37-19(11-35-17)25-41-39-23(43-25)13-4-1-5-14(10-13)24-40-42-26(44-24)20-12-36-18-9-3-7-16(22(18)38-20)28(32,33)34;1-15-6-3-10-19-23(15)31-21(13-29-19)27-35-33-25(37-27)17-8-5-9-18(12-17)26-34-36-28(38-26)22-14-30-20-11-4-7-16(2)24(20)32-22;27-15-6-2-8-17-21(15)31-19(11-29-17)25-35-33-23(37-25)13-4-1-5-14(10-13)24-34-36-26(38-24)20-12-30-18-9-3-7-16(28)22(18)32-20;1-4-17(23-31-33-25(35-23)19-10-8-15-6-2-12-27-21(15)29-19)14-18(5-1)24-32-34-26(36-24)20-11-9-16-7-3-13-28-22(16)30-20;1-2-17(23-31-33-25(35-23)19-6-4-15-8-10-27-13-21(15)29-19)12-18(3-1)24-32-34-26(36-24)20-7-5-16-9-11-28-14-22(16)30-20;1-4-11(15-23-25-17(27-15)13-19-6-2-7-20-13)10-12(5-1)16-24-26-18(28-16)14-21-8-3-9-22-14;;;;;;;/h2*1-22H;1-18H;1-12H;3-14H,1-2H3;1-12H;2*1-14H;1-10H;7*1H4
InChIKeyVPLYBWJKCVAWNO-UHFFFAOYSA-N
MW4802.74 g/mol
LogP57.84
Rot. Bonds42

About 2-(8-fluoroquinoxalin-2-yl)-5-[3-[5-(8-fluoroquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;methane;2-(8-methylquinoxalin-2-yl)-5-[3-[5-(8-methylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,7-naphthyridin-2-yl)-5-[3-[5-(1,7-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,8-naphthyridin-2-yl)-5-[3-[5-(1,8-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(6-phenylpyrimidin-4-yl)-5-[3-[5-(6-phenylpyrimidin-4-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(7-phenylquinoxalin-2-yl)-5-[3-[5-(7-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(8-phenylquinoxalin-2-yl)-5-[3-[5-(8-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-pyrimidin-2-yl-5-[3-(5-pyrimidin-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-1,3,4-oxadiazole;2-[8-(trifluoromethyl)quinoxalin-2-yl]-5-[3-[5-[8-(trifluoromethyl)quinoxalin-2-yl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole

2-(8-fluoroquinoxalin-2-yl)-5-[3-[5-(8-fluoroquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;methane;2-(8-methylquinoxalin-2-yl)-5-[3-[5-(8-methylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,7-naphthyridin-2-yl)-5-[3-[5-(1,7-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,8-naphthyridin-2-yl)-5-[3-[5-(1,8-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(6-phenylpyrimidin-4-yl)-5-[3-[5-(6-phenylpyrimidin-4-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(7-phenylquinoxalin-2-yl)-5-[3-[5-(7-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(8-phenylquinoxalin-2-yl)-5-[3-[5-(8-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-pyrimidin-2-yl-5-[3-(5-pyrimidin-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-1,3,4-oxadiazole;2-[8-(trifluoromethyl)quinoxalin-2-yl]-5-[3-[5-[8-(trifluoromethyl)quinoxalin-2-yl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole (PubChem CID 161363274) has the molecular formula C265H170F8N72O18 and a molecular weight of 4802.74 g/mol. Its IUPAC name is 2-(8-fluoroquinoxalin-2-yl)-5-[3-[5-(8-fluoroquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;methane;2-(8-methylquinoxalin-2-yl)-5-[3-[5-(8-methylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,7-naphthyridin-2-yl)-5-[3-[5-(1,7-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,8-naphthyridin-2-yl)-5-[3-[5-(1,8-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(6-phenylpyrimidin-4-yl)-5-[3-[5-(6-phenylpyrimidin-4-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(7-phenylquinoxalin-2-yl)-5-[3-[5-(7-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(8-phenylquinoxalin-2-yl)-5-[3-[5-(8-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-pyrimidin-2-yl-5-[3-(5-pyrimidin-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-1,3,4-oxadiazole;2-[8-(trifluoromethyl)quinoxalin-2-yl]-5-[3-[5-[8-(trifluoromethyl)quinoxalin-2-yl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole.

Molecular Properties

Compound Name2-(8-fluoroquinoxalin-2-yl)-5-[3-[5-(8-fluoroquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;methane;2-(8-methylquinoxalin-2-yl)-5-[3-[5-(8-methylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,7-naphthyridin-2-yl)-5-[3-[5-(1,7-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,8-naphthyridin-2-yl)-5-[3-[5-(1,8-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(6-phenylpyrimidin-4-yl)-5-[3-[5-(6-phenylpyrimidin-4-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(7-phenylquinoxalin-2-yl)-5-[3-[5-(7-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(8-phenylquinoxalin-2-yl)-5-[3-[5-(8-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-pyrimidin-2-yl-5-[3-(5-pyrimidin-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-1,3,4-oxadiazole;2-[8-(trifluoromethyl)quinoxalin-2-yl]-5-[3-[5-[8-(trifluoromethyl)quinoxalin-2-yl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole
PubChem CID161363274
Molecular FormulaC265H170F8N72O18
Molecular Weight4802.74 g/mol
Exact Mass4799.45
IUPAC Name2-(8-fluoroquinoxalin-2-yl)-5-[3-[5-(8-fluoroquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;methane;2-(8-methylquinoxalin-2-yl)-5-[3-[5-(8-methylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,7-naphthyridin-2-yl)-5-[3-[5-(1,7-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,8-naphthyridin-2-yl)-5-[3-[5-(1,8-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(6-phenylpyrimidin-4-yl)-5-[3-[5-(6-phenylpyrimidin-4-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(7-phenylquinoxalin-2-yl)-5-[3-[5-(7-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(8-phenylquinoxalin-2-yl)-5-[3-[5-(8-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-pyrimidin-2-yl-5-[3-(5-pyrimidin-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-1,3,4-oxadiazole;2-[8-(trifluoromethyl)quinoxalin-2-yl]-5-[3-[5-[8-(trifluoromethyl)quinoxalin-2-yl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole
SMILESC.C.C.C.C.C.C.Cc1cccc2ncc(-c3nnc(-c4cccc(-c5nnc(-c6cnc7cccc(C)c7n6)o5)c4)o3)nc12.FC(F)(F)c1cccc2ncc(-c3nnc(-c4cccc(-c5nnc(-c6cnc7cccc(C(F)(F)F)c7n6)o5)c4)o3)nc12.Fc1cccc2ncc(-c3nnc(-c4cccc(-c5nnc(-c6cnc7cccc(F)c7n6)o5)c4)o3)nc12.c1cc(-c2nnc(-c3ccc4cccnc4n3)o2)cc(-c2nnc(-c3ccc4cccnc4n3)o2)c1.c1cc(-c2nnc(-c3ccc4ccncc4n3)o2)cc(-c2nnc(-c3ccc4ccncc4n3)o2)c1.c1ccc(-c2cc(-c3nnc(-c4cccc(-c5nnc(-c6cc(-c7ccccc7)ncn6)o5)c4)o3)ncn2)cc1.c1ccc(-c2ccc3ncc(-c4nnc(-c5cccc(-c6nnc(-c7cnc8ccc(-c9ccccc9)cc8n7)o6)c5)o4)nc3c2)cc1.c1ccc(-c2cccc3ncc(-c4nnc(-c5cccc(-c6nnc(-c7cnc8cccc(-c9ccccc9)c8n7)o6)c5)o4)nc23)cc1.c1cnc(-c2nnc(-c3cccc(-c4nnc(-c5ncccn5)o4)c3)o2)nc1
InChIInChI=1S/2C38H22N8O2.C30H18N8O2.C28H12F6N8O2.C28H18N8O2.C26H12F2N8O2.2C26H14N8O2.C18H10N8O2.7CH4/c1-3-10-23(11-4-1)27-16-8-18-29-33(27)41-31(21-39-29)37-45-43-35(47-37)25-14-7-15-26(20-25)36-44-46-38(48-36)32-22-40-30-19-9-17-28(34(30)42-32)24-12-5-2-6-13-24;1-3-8-23(9-4-1)25-14-16-29-31(19-25)41-33(21-39-29)37-45-43-35(47-37)27-12-7-13-28(18-27)36-44-46-38(48-36)34-22-40-30-17-15-26(20-32(30)42-34)24-10-5-2-6-11-24;1-3-8-19(9-4-1)23-15-25(33-17-31-23)29-37-35-27(39-29)21-12-7-13-22(14-21)28-36-38-30(40-28)26-16-24(32-18-34-26)20-10-5-2-6-11-20;29-27(30,31)15-6-2-8-17-21(15)37-19(11-35-17)25-41-39-23(43-25)13-4-1-5-14(10-13)24-40-42-26(44-24)20-12-36-18-9-3-7-16(22(18)38-20)28(32,33)34;1-15-6-3-10-19-23(15)31-21(13-29-19)27-35-33-25(37-27)17-8-5-9-18(12-17)26-34-36-28(38-26)22-14-30-20-11-4-7-16(2)24(20)32-22;27-15-6-2-8-17-21(15)31-19(11-29-17)25-35-33-23(37-25)13-4-1-5-14(10-13)24-34-36-26(38-24)20-12-30-18-9-3-7-16(28)22(18)32-20;1-4-17(23-31-33-25(35-23)19-10-8-15-6-2-12-27-21(15)29-19)14-18(5-1)24-32-34-26(36-24)20-11-9-16-7-3-13-28-22(16)30-20;1-2-17(23-31-33-25(35-23)19-6-4-15-8-10-27-13-21(15)29-19)12-18(3-1)24-32-34-26(36-24)20-7-5-16-9-11-28-14-22(16)30-20;1-4-11(15-23-25-17(27-15)13-19-6-2-7-20-13)10-12(5-1)16-24-26-18(28-16)14-21-8-3-9-22-14;;;;;;;/h2*1-22H;1-18H;1-12H;3-14H,1-2H3;1-12H;2*1-14H;1-10H;7*1H4
InChIKeyVPLYBWJKCVAWNO-UHFFFAOYSA-N
XLogP57.84
TPSA1164.60 Ų
H-Bond Donors
H-Bond Acceptors90
Rotatable Bonds42
Heavy Atoms363
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5004802.74
LogP ≤ 557.84
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1090

Analyze 2-(8-fluoroquinoxalin-2-yl)-5-[3-[5-(8-fluoroquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;methane;2-(8-methylquinoxalin-2-yl)-5-[3-[5-(8-methylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,7-naphthyridin-2-yl)-5-[3-[5-(1,7-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,8-naphthyridin-2-yl)-5-[3-[5-(1,8-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(6-phenylpyrimidin-4-yl)-5-[3-[5-(6-phenylpyrimidin-4-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(7-phenylquinoxalin-2-yl)-5-[3-[5-(7-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(8-phenylquinoxalin-2-yl)-5-[3-[5-(8-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-pyrimidin-2-yl-5-[3-(5-pyrimidin-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-1,3,4-oxadiazole;2-[8-(trifluoromethyl)quinoxalin-2-yl]-5-[3-[5-[8-(trifluoromethyl)quinoxalin-2-yl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-(8-fluoroquinoxalin-2-yl)-5-[3-[5-(8-fluoroquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;methane;2-(8-methylquinoxalin-2-yl)-5-[3-[5-(8-methylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,7-naphthyridin-2-yl)-5-[3-[5-(1,7-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,8-naphthyridin-2-yl)-5-[3-[5-(1,8-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(6-phenylpyrimidin-4-yl)-5-[3-[5-(6-phenylpyrimidin-4-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(7-phenylquinoxalin-2-yl)-5-[3-[5-(7-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(8-phenylquinoxalin-2-yl)-5-[3-[5-(8-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-pyrimidin-2-yl-5-[3-(5-pyrimidin-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-1,3,4-oxadiazole;2-[8-(trifluoromethyl)quinoxalin-2-yl]-5-[3-[5-[8-(trifluoromethyl)quinoxalin-2-yl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole?
The IUPAC name of 2-(8-fluoroquinoxalin-2-yl)-5-[3-[5-(8-fluoroquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;methane;2-(8-methylquinoxalin-2-yl)-5-[3-[5-(8-methylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,7-naphthyridin-2-yl)-5-[3-[5-(1,7-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,8-naphthyridin-2-yl)-5-[3-[5-(1,8-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(6-phenylpyrimidin-4-yl)-5-[3-[5-(6-phenylpyrimidin-4-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(7-phenylquinoxalin-2-yl)-5-[3-[5-(7-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(8-phenylquinoxalin-2-yl)-5-[3-[5-(8-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-pyrimidin-2-yl-5-[3-(5-pyrimidin-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-1,3,4-oxadiazole;2-[8-(trifluoromethyl)quinoxalin-2-yl]-5-[3-[5-[8-(trifluoromethyl)quinoxalin-2-yl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole (CID 161363274) is 2-(8-fluoroquinoxalin-2-yl)-5-[3-[5-(8-fluoroquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;methane;2-(8-methylquinoxalin-2-yl)-5-[3-[5-(8-methylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,7-naphthyridin-2-yl)-5-[3-[5-(1,7-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,8-naphthyridin-2-yl)-5-[3-[5-(1,8-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(6-phenylpyrimidin-4-yl)-5-[3-[5-(6-phenylpyrimidin-4-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(7-phenylquinoxalin-2-yl)-5-[3-[5-(7-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(8-phenylquinoxalin-2-yl)-5-[3-[5-(8-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-pyrimidin-2-yl-5-[3-(5-pyrimidin-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-1,3,4-oxadiazole;2-[8-(trifluoromethyl)quinoxalin-2-yl]-5-[3-[5-[8-(trifluoromethyl)quinoxalin-2-yl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole.
What is the SMILES notation for 2-(8-fluoroquinoxalin-2-yl)-5-[3-[5-(8-fluoroquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;methane;2-(8-methylquinoxalin-2-yl)-5-[3-[5-(8-methylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,7-naphthyridin-2-yl)-5-[3-[5-(1,7-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,8-naphthyridin-2-yl)-5-[3-[5-(1,8-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(6-phenylpyrimidin-4-yl)-5-[3-[5-(6-phenylpyrimidin-4-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(7-phenylquinoxalin-2-yl)-5-[3-[5-(7-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(8-phenylquinoxalin-2-yl)-5-[3-[5-(8-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-pyrimidin-2-yl-5-[3-(5-pyrimidin-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-1,3,4-oxadiazole;2-[8-(trifluoromethyl)quinoxalin-2-yl]-5-[3-[5-[8-(trifluoromethyl)quinoxalin-2-yl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole?
The canonical SMILES for 2-(8-fluoroquinoxalin-2-yl)-5-[3-[5-(8-fluoroquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;methane;2-(8-methylquinoxalin-2-yl)-5-[3-[5-(8-methylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,7-naphthyridin-2-yl)-5-[3-[5-(1,7-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,8-naphthyridin-2-yl)-5-[3-[5-(1,8-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(6-phenylpyrimidin-4-yl)-5-[3-[5-(6-phenylpyrimidin-4-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(7-phenylquinoxalin-2-yl)-5-[3-[5-(7-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(8-phenylquinoxalin-2-yl)-5-[3-[5-(8-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-pyrimidin-2-yl-5-[3-(5-pyrimidin-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-1,3,4-oxadiazole;2-[8-(trifluoromethyl)quinoxalin-2-yl]-5-[3-[5-[8-(trifluoromethyl)quinoxalin-2-yl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole is C.C.C.C.C.C.C.Cc1cccc2ncc(-c3nnc(-c4cccc(-c5nnc(-c6cnc7cccc(C)c7n6)o5)c4)o3)nc12.FC(F)(F)c1cccc2ncc(-c3nnc(-c4cccc(-c5nnc(-c6cnc7cccc(C(F)(F)F)c7n6)o5)c4)o3)nc12.Fc1cccc2ncc(-c3nnc(-c4cccc(-c5nnc(-c6cnc7cccc(F)c7n6)o5)c4)o3)nc12.c1cc(-c2nnc(-c3ccc4cccnc4n3)o2)cc(-c2nnc(-c3ccc4cccnc4n3)o2)c1.c1cc(-c2nnc(-c3ccc4ccncc4n3)o2)cc(-c2nnc(-c3ccc4ccncc4n3)o2)c1.c1ccc(-c2cc(-c3nnc(-c4cccc(-c5nnc(-c6cc(-c7ccccc7)ncn6)o5)c4)o3)ncn2)cc1.c1ccc(-c2ccc3ncc(-c4nnc(-c5cccc(-c6nnc(-c7cnc8ccc(-c9ccccc9)cc8n7)o6)c5)o4)nc3c2)cc1.c1ccc(-c2cccc3ncc(-c4nnc(-c5cccc(-c6nnc(-c7cnc8cccc(-c9ccccc9)c8n7)o6)c5)o4)nc23)cc1.c1cnc(-c2nnc(-c3cccc(-c4nnc(-c5ncccn5)o4)c3)o2)nc1.
What is the InChIKey of 2-(8-fluoroquinoxalin-2-yl)-5-[3-[5-(8-fluoroquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;methane;2-(8-methylquinoxalin-2-yl)-5-[3-[5-(8-methylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,7-naphthyridin-2-yl)-5-[3-[5-(1,7-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,8-naphthyridin-2-yl)-5-[3-[5-(1,8-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(6-phenylpyrimidin-4-yl)-5-[3-[5-(6-phenylpyrimidin-4-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(7-phenylquinoxalin-2-yl)-5-[3-[5-(7-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(8-phenylquinoxalin-2-yl)-5-[3-[5-(8-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-pyrimidin-2-yl-5-[3-(5-pyrimidin-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-1,3,4-oxadiazole;2-[8-(trifluoromethyl)quinoxalin-2-yl]-5-[3-[5-[8-(trifluoromethyl)quinoxalin-2-yl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole?
The InChIKey is VPLYBWJKCVAWNO-UHFFFAOYSA-N. The full InChI is InChI=1S/2C38H22N8O2.C30H18N8O2.C28H12F6N8O2.C28H18N8O2.C26H12F2N8O2.2C26H14N8O2.C18H10N8O2.7CH4/c1-3-10-23(11-4-1)27-16-8-18-29-33(27)41-31(21-39-29)37-45-43-35(47-37)25-14-7-15-26(20-25)36-44-46-38(48-36)32-22-40-30-19-9-17-28(34(30)42-32)24-12-5-2-6-13-24;1-3-8-23(9-4-1)25-14-16-29-31(19-25)41-33(21-39-29)37-45-43-35(47-37)27-12-7-13-28(18-27)36-44-46-38(48-36)34-22-40-30-17-15-26(20-32(30)42-34)24-10-5-2-6-11-24;1-3-8-19(9-4-1)23-15-25(33-17-31-23)29-37-35-27(39-29)21-12-7-13-22(14-21)28-36-38-30(40-28)26-16-24(32-18-34-26)20-10-5-2-6-11-20;29-27(30,31)15-6-2-8-17-21(15)37-19(11-35-17)25-41-39-23(43-25)13-4-1-5-14(10-13)24-40-42-26(44-24)20-12-36-18-9-3-7-16(22(18)38-20)28(32,33)34;1-15-6-3-10-19-23(15)31-21(13-29-19)27-35-33-25(37-27)17-8-5-9-18(12-17)26-34-36-28(38-26)22-14-30-20-11-4-7-16(2)24(20)32-22;27-15-6-2-8-17-21(15)31-19(11-29-17)25-35-33-23(37-25)13-4-1-5-14(10-13)24-34-36-26(38-24)20-12-30-18-9-3-7-16(28)22(18)32-20;1-4-17(23-31-33-25(35-23)19-10-8-15-6-2-12-27-21(15)29-19)14-18(5-1)24-32-34-26(36-24)20-11-9-16-7-3-13-28-22(16)30-20;1-2-17(23-31-33-25(35-23)19-6-4-15-8-10-27-13-21(15)29-19)12-18(3-1)24-32-34-26(36-24)20-7-5-16-9-11-28-14-22(16)30-20;1-4-11(15-23-25-17(27-15)13-19-6-2-7-20-13)10-12(5-1)16-24-26-18(28-16)14-21-8-3-9-22-14;;;;;;;/h2*1-22H;1-18H;1-12H;3-14H,1-2H3;1-12H;2*1-14H;1-10H;7*1H4.
What are the key properties of 2-(8-fluoroquinoxalin-2-yl)-5-[3-[5-(8-fluoroquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;methane;2-(8-methylquinoxalin-2-yl)-5-[3-[5-(8-methylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,7-naphthyridin-2-yl)-5-[3-[5-(1,7-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,8-naphthyridin-2-yl)-5-[3-[5-(1,8-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(6-phenylpyrimidin-4-yl)-5-[3-[5-(6-phenylpyrimidin-4-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(7-phenylquinoxalin-2-yl)-5-[3-[5-(7-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(8-phenylquinoxalin-2-yl)-5-[3-[5-(8-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-pyrimidin-2-yl-5-[3-(5-pyrimidin-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-1,3,4-oxadiazole;2-[8-(trifluoromethyl)quinoxalin-2-yl]-5-[3-[5-[8-(trifluoromethyl)quinoxalin-2-yl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole?
2-(8-fluoroquinoxalin-2-yl)-5-[3-[5-(8-fluoroquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;methane;2-(8-methylquinoxalin-2-yl)-5-[3-[5-(8-methylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,7-naphthyridin-2-yl)-5-[3-[5-(1,7-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,8-naphthyridin-2-yl)-5-[3-[5-(1,8-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(6-phenylpyrimidin-4-yl)-5-[3-[5-(6-phenylpyrimidin-4-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(7-phenylquinoxalin-2-yl)-5-[3-[5-(7-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(8-phenylquinoxalin-2-yl)-5-[3-[5-(8-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-pyrimidin-2-yl-5-[3-(5-pyrimidin-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-1,3,4-oxadiazole;2-[8-(trifluoromethyl)quinoxalin-2-yl]-5-[3-[5-[8-(trifluoromethyl)quinoxalin-2-yl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole has a molecular weight of 4802.74 g/mol, XLogP of 57.84, 42 rotatable bonds, 0 hydrogen bond donors, and 90 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(8-fluoroquinoxalin-2-yl)-5-[3-[5-(8-fluoroquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;methane;2-(8-methylquinoxalin-2-yl)-5-[3-[5-(8-methylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,7-naphthyridin-2-yl)-5-[3-[5-(1,7-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(1,8-naphthyridin-2-yl)-5-[3-[5-(1,8-naphthyridin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(6-phenylpyrimidin-4-yl)-5-[3-[5-(6-phenylpyrimidin-4-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(7-phenylquinoxalin-2-yl)-5-[3-[5-(7-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-(8-phenylquinoxalin-2-yl)-5-[3-[5-(8-phenylquinoxalin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole;2-pyrimidin-2-yl-5-[3-(5-pyrimidin-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-1,3,4-oxadiazole;2-[8-(trifluoromethyl)quinoxalin-2-yl]-5-[3-[5-[8-(trifluoromethyl)quinoxalin-2-yl]-1,3,4-oxadiazol-2-yl]phenyl]-1,3,4-oxadiazole is sourced from PubChem (CID 161363274), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).